C M Ardila1, M I Granada, I C Guzmán. 1. Epidemiology Group, University of Antioquia, Medellín, Colombia. martinardila@gmail.com
Abstract
BACKGROUND AND OBJECTIVE: The increasing rate of resistance of microorganisms to penicillin and other antibiotics has generated concern among health authorities in Latin America. The present investigation determined the in vitro susceptibility of Porphyromonas gingivalis, Fusobacterium nucleatum, black-pigmented Prevotella spp. and Aggregatibacter actinomycetemcomitans to metronidazole, amoxicillin, amoxicillin/clavulanic acid, clindamycin and moxifloxacin in patients with chronic periodontitis. MATERIAL AND METHODS: Subgingival plaque samples from patients with periodontitis were collected and cultured on selective and nonselective culture media. The antimicrobial susceptibility of periodontopathogenic isolates was studied in chronic periodontitis patients in Colombia. Metronidazole, amoxicillin, amoxicillin/clavulanic acid, clindamycin and moxifloxacin were tested on all bacterial isolates and the percentage of resistant strains was calculated. RESULTS: Of the 150 bacteria identified, 51 were P. gingivalis, 45 were black-pigmented Prevotella spp., 36 were F. nucleatum and 18 were A. actinomycetemcomitans. All the isolates were sensitive to amoxicillin/clavulanic acid and to moxifloxacin, but exhibited variable susceptibility patterns to the other antimicrobial agents tested. CONCLUSION: The results of the present study suggest that periodontal microorganisms in patients with chronic periodontitis can be resistant to the antimicrobial agents commonly used in anti-infective periodontal therapy. We suggest that the indiscriminate use of antimicrobials could result in the appearance of more highly antibiotic-resistant strains of bacteria associated with periodontal diseases in our population compared with the populations of other countries.
BACKGROUND AND OBJECTIVE: The increasing rate of resistance of microorganisms to penicillin and other antibiotics has generated concern among health authorities in Latin America. The present investigation determined the in vitro susceptibility of Porphyromonas gingivalis, Fusobacterium nucleatum, black-pigmented Prevotella spp. and Aggregatibacter actinomycetemcomitans to metronidazole, amoxicillin, amoxicillin/clavulanic acid, clindamycin and moxifloxacin in patients with chronic periodontitis. MATERIAL AND METHODS: Subgingival plaque samples from patients with periodontitis were collected and cultured on selective and nonselective culture media. The antimicrobial susceptibility of periodontopathogenic isolates was studied in chronic periodontitispatients in Colombia. Metronidazole, amoxicillin, amoxicillin/clavulanic acid, clindamycin and moxifloxacin were tested on all bacterial isolates and the percentage of resistant strains was calculated. RESULTS: Of the 150 bacteria identified, 51 were P. gingivalis, 45 were black-pigmented Prevotella spp., 36 were F. nucleatum and 18 were A. actinomycetemcomitans. All the isolates were sensitive to amoxicillin/clavulanic acid and to moxifloxacin, but exhibited variable susceptibility patterns to the other antimicrobial agents tested. CONCLUSION: The results of the present study suggest that periodontal microorganisms in patients with chronic periodontitis can be resistant to the antimicrobial agents commonly used in anti-infective periodontal therapy. We suggest that the indiscriminate use of antimicrobials could result in the appearance of more highly antibiotic-resistant strains of bacteria associated with periodontal diseases in our population compared with the populations of other countries.
Authors: Kirk E Hevener; Shahila Mehboob; Teuta Boci; Kent Truong; Bernard D Santarsiero; Michael E Johnson Journal: Protein Expr Purif Date: 2012-07-20 Impact factor: 1.650
Authors: Mangala A Nadkarni; Kim-Ly Chhour; Gina V Browne; Roy Byun; Ky-Anh Nguyen; Cheryl C Chapple; Nicholas A Jacques; Neil Hunter Journal: Clin Oral Investig Date: 2014-08-09 Impact factor: 3.573
Authors: S Pattnaik; N Anand; S C Chandrasekaran; L Chandrashekar; K Mahalakshmi; A Satpathy Journal: Eur J Clin Microbiol Infect Dis Date: 2015-07-26 Impact factor: 3.267
Authors: Laura J Sherrard; Kathryn A Graham; Stef J McGrath; Leanne McIlreavey; Joseph Hatch; Marianne S Muhlebach; Matthew C Wolfgang; Deirdre F Gilpin; J Stuart Elborn; Thamarai Schneiders; Michael M Tunney Journal: J Antimicrob Chemother Date: 2013-05-21 Impact factor: 5.790
Authors: Marco C Bottino; Rodrigo A Arthur; R Aaron Waeiss; Krzysztof Kamocki; Karen S Gregson; Richard L Gregory Journal: Clin Oral Investig Date: 2014-02-18 Impact factor: 3.573